Financhill
Buy
66

IX Quote, Financials, Valuation and Earnings

Last price:
$29.51
Seasonality move :
-0.85%
Day range:
$29.39 - $29.67
52-week range:
$17.75 - $29.68
Dividend yield:
3.38%
P/E ratio:
11.36x
P/S ratio:
1.65x
P/B ratio:
1.10x
Volume:
138.7K
Avg. volume:
168.7K
1-year change:
39.33%
Market cap:
$33B
Revenue:
$18.9B
EPS (TTM):
$2.61

Analysts' Opinion

  • Consensus Rating
    ORIX Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $30.15, ORIX Corp. has an estimated upside of 1.63% from its current price of $29.54.
  • Price Target Downside
    According to analysts, the lowest downside price target is $30.15 representing 100% downside risk from its current price of $29.54.

Fair Value

  • According to the consensus of 1 analyst, ORIX Corp. has 1.63% upside to fair value with a price target of $30.15 per share.

IX vs. S&P 500

  • Over the past 5 trading days, ORIX Corp. has overperformed the S&P 500 by 0.73% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • ORIX Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • ORIX Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter ORIX Corp. reported revenues of $5.4B.

Earnings Growth

  • ORIX Corp. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter ORIX Corp. reported earnings per share of $0.99.
Enterprise value:
68.5B
EV / Invested capital:
0.91x
Price / LTM sales:
1.65x
EV / EBIT:
16.64x
EV / Revenue:
3.36x
PEG ratio (5yr expected):
5.48x
EV / Free cash flow:
8.44x
Price / Operating cash flow:
80.13x
Enterprise value / EBITDA:
10.11x
Gross Profit (TTM):
$8.6B
Return On Assets:
2.62%
Net Income Margin (TTM):
14.69%
Return On Equity:
10.5%
Return On Invested Capital:
4.16%
Operating Margin:
20.61%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $19.2B $19.1B $20.4B $4.7B $5.4B
Gross Profit $8.2B $8.3B $8.6B $2.1B $2.3B
Operating Income $3.9B $4B $4.1B $1.1B $1.1B
EBITDA $6.5B $6.6B $6.8B $1.8B $1.8B
Diluted EPS $1.82 $9.45 $2.61 $2.81 $0.99
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $18.3B $14.3B $15.6B $13.1B $13.5B
Total Assets $124B $102.2B $105.8B $114.2B $119.2B
Current Liabilities $10.2B $7.1B $9.4B $11.1B $10.8B
Total Liabilities $95.2B $78.3B $80.1B $86.4B $88.3B
Total Equity $28.8B $23.9B $25.8B $27.8B $30.9B
Total Debt $42.3B $36.8B $39.7B $38.4B $40B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-03-31 2023-03-31 2024-03-31 2023-03-31 2024-03-31
Cash Flow Statement
Cash Flow Operations $9.2B $6.5B $8.7B $2.4B $2.2B
Cash From Investing -$7B -$8.4B -$9.4B -$3.3B -$901.9M
Cash From Financing -$2.9B $3.5B -$698.4M $3B -$273.4M
Free Cash Flow $8.8B $5.7B $8.1B $2.2B $2B
IX
Sector
Market Cap
$33B
$570M
Price % of 52-Week High
99.97%
92.18%
Dividend Yield
3.38%
1.57%
Shareholder Yield
0.77%
3.12%
1-Year Price Total Return
39.9%
7.87%
Beta (5-Year)
0.744
0.478
Dividend yield:
3.38%
Annualized payout:
$0.82
Payout ratio:
40.92%
Growth streak:
2 years

Technicals

8-day SMA
Buy
Level $29.07
200-day SMA
Buy
Level $23.68
Bollinger Bands (100)
Buy
Level 24.87 - 27.53
Chaikin Money Flow
Buy
Level 76.5M
20-day SMA
Buy
Level $28.31
Relative Strength Index (RSI14)
Buy
Level 70.24
ADX Line
Buy
Level 35.56
Williams %R
Sell
Level -0.4831
50-day SMA
Buy
Level $26.48
MACD (12, 26)
Buy
Level 0.82
25-day Aroon Oscillator
Buy
Level 96
On Balance Volume
Neutral
Level 9.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.8326)
Sell
CA Score (Annual)
Level (-1.4298)
Buy
Beneish M-Score (Annual)
Level (-3.4914)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.0086)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

ORIX Corp. engages in the provision of leasing and corporate financial services. It operates through the following segments: Corporate Financial Services, Maintenance Leasing, Real Estate, Investment and Operation, Retail, and Overseas Business. The Corporate Financial Services segment offers leasing and loans to small and medium-sized enterprises. The Maintenance Leasing segment consists of automobile leasing, car sharing, and equipment rental services. The Real Estate segment deals with property development, leasing, and facilities management. The Investment and Operation segment comprises of environment and energy-related business, loan servicing, and principal investments. The Retail segment offers life insurance, banking, and card loan services. The Overseas Business segment engages in financial services through overseas subsidiaries, business development and investment with business partners abroad, and aircraft and ship-related businesses. The company was founded on April 17, 1964 and is headquartered in Tokyo, Japan.

Stock Forecast FAQ

In the current month, IX has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The IX average analyst price target in the past 3 months is $30.15.

  • Where Will ORIX Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that ORIX Corp. share price will rise to $30.15 per share over the next 12 months.

  • What Do Analysts Say About ORIX Corp.?

    Analysts are divided on their view about ORIX Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ORIX Corp. is a Sell and believe this share price will drop from its current level to $30.15.

  • What Is ORIX Corp.'s Price Target?

    The price target for ORIX Corp. over the next 1-year time period is forecast to be $30.15 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.

  • Is IX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for ORIX Corp. is a Hold. 1 of 1 analysts rates the stock a Hold at this time.

  • How Can I Buy Shares Of IX?

    You can purchase shares of ORIX Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ORIX Corp. shares.

  • What Is The ORIX Corp. Share Price Today?

    ORIX Corp. was last trading at $29.51 per share. This represents the most recent stock quote for ORIX Corp.. Yesterday, ORIX Corp. closed at $29.54 per share.

  • How To Buy ORIX Corp. Stock Online?

    In order to purchase ORIX Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock